Investigation of Anti-Toxocara and Anti-Toxoplasma Antibodies in Patients with Schizophrenia Disorder

Table 5

The seroprevalence of anti-T. gondii IgG antibodies in patients with schizophrenia disorder based on gender.

	Patients’ group
	𝑁 (%)		Sig	OR	CI
	Male	Female
Toxoplasma  gondii	16/65 (24.61%)	18/35 (51.42%)	0.009	0.3	0.12–0.73
Toxocara	8/65 (12.30%)	6/35 (17.14%)	0.5	1.47	0.46–4.65